AU2001241420A1 - Screening assays using intramitochondrial calcium - Google Patents

Screening assays using intramitochondrial calcium

Info

Publication number
AU2001241420A1
AU2001241420A1 AU2001241420A AU4142001A AU2001241420A1 AU 2001241420 A1 AU2001241420 A1 AU 2001241420A1 AU 2001241420 A AU2001241420 A AU 2001241420A AU 4142001 A AU4142001 A AU 4142001A AU 2001241420 A1 AU2001241420 A1 AU 2001241420A1
Authority
AU
Australia
Prior art keywords
mitochondrial
agents
screening assays
calcium
detect
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001241420A
Other languages
English (en)
Inventor
Anne N. Murphy
Amy K. Stout
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Migenix Corp
Original Assignee
Mitokor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitokor Inc filed Critical Mitokor Inc
Publication of AU2001241420A1 publication Critical patent/AU2001241420A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5076—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving cell organelles, e.g. Golgi complex, endoplasmic reticulum
    • G01N33/5079—Mitochondria

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2001241420A 2000-01-14 2001-01-16 Screening assays using intramitochondrial calcium Abandoned AU2001241420A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17638400P 2000-01-14 2000-01-14
US60176384 2000-01-14
PCT/US2001/001500 WO2001051923A2 (fr) 2000-01-14 2001-01-16 Tests de criblage utilisant le calcium intramitochondrial

Publications (1)

Publication Number Publication Date
AU2001241420A1 true AU2001241420A1 (en) 2001-07-24

Family

ID=22644141

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001241420A Abandoned AU2001241420A1 (en) 2000-01-14 2001-01-16 Screening assays using intramitochondrial calcium

Country Status (6)

Country Link
US (2) US6808873B2 (fr)
EP (1) EP1247093B1 (fr)
AT (1) ATE291737T1 (fr)
AU (1) AU2001241420A1 (fr)
DE (1) DE60109571D1 (fr)
WO (1) WO2001051923A2 (fr)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7718644B2 (en) 2004-01-22 2010-05-18 The Trustees Of Columbia University In The City Of New York Anti-arrhythmic and heart failure drugs that target the leak in the ryanodine receptor (RyR2) and uses thereof
US7879840B2 (en) 2005-08-25 2011-02-01 The Trustees Of Columbia University In The City Of New York Agents for preventing and treating disorders involving modulation of the RyR receptors
US8022058B2 (en) * 2000-05-10 2011-09-20 The Trustees Of Columbia University In The City Of New York Agents for preventing and treating disorders involving modulation of the RyR receptors
WO2002002816A2 (fr) * 2000-06-29 2002-01-10 Mitokor Procedes d'identification de transporteurs de cations divalents mitochondriaux
EP2383280A1 (fr) 2002-09-23 2011-11-02 E. I. du Pont de Nemours and Company Système d'expression pour les canaux d'ion toxiques, par example de récepteurs de la ryanodine
ATE468114T1 (de) * 2002-11-08 2010-06-15 High Point Pharmaceuticals Llc Sichere chemische entkuppler zur behandlung von fettsucht
GB0228139D0 (en) * 2002-12-03 2003-01-08 Kozlova Zwinderman Olga Fungal biosensor for contaminant detection
US8710045B2 (en) 2004-01-22 2014-04-29 The Trustees Of Columbia University In The City Of New York Agents for preventing and treating disorders involving modulation of the ryanodine receptors
US9274099B2 (en) 2005-07-22 2016-03-01 The Board Of Trustees Of The Leland Stanford Junior University Screening test drugs to identify their effects on cell membrane voltage-gated ion channel
US8926959B2 (en) 2005-07-22 2015-01-06 The Board Of Trustees Of The Leland Stanford Junior University System for optical stimulation of target cells
US9238150B2 (en) 2005-07-22 2016-01-19 The Board Of Trustees Of The Leland Stanford Junior University Optical tissue interface method and apparatus for stimulating cells
US20090093403A1 (en) 2007-03-01 2009-04-09 Feng Zhang Systems, methods and compositions for optical stimulation of target cells
US10052497B2 (en) 2005-07-22 2018-08-21 The Board Of Trustees Of The Leland Stanford Junior University System for optical stimulation of target cells
EP1919497B1 (fr) 2005-07-22 2020-02-12 The Board of Trustees of the Leland Stanford Junior University Canaux cationiques activees par la lumiere et leurs utilisations
US7704990B2 (en) 2005-08-25 2010-04-27 The Trustees Of Columbia University In The City Of New York Agents for preventing and treating disorders involving modulation of the RyR receptors
WO2007065080A2 (fr) * 2005-11-29 2007-06-07 University Of Maryland, College Park Suppression de l’apoptose par regulation de la propension a la formation de chaine de ceramide
US8398692B2 (en) 2007-01-10 2013-03-19 The Board Of Trustees Of The Leland Stanford Junior University System for optical stimulation of target cells
US8795609B2 (en) 2007-02-08 2014-08-05 Biokit, S.A. Magnetic particle washing station
US8401609B2 (en) 2007-02-14 2013-03-19 The Board Of Trustees Of The Leland Stanford Junior University System, method and applications involving identification of biological circuits such as neurological characteristics
US10434327B2 (en) 2007-10-31 2019-10-08 The Board Of Trustees Of The Leland Stanford Junior University Implantable optical stimulators
US10035027B2 (en) 2007-10-31 2018-07-31 The Board Of Trustees Of The Leland Stanford Junior University Device and method for ultrasonic neuromodulation via stereotactic frame based technique
SG189813A1 (en) 2008-04-23 2013-05-31 Univ Leland Stanford Junior Systems, methods and compositions for optical stimulation of target cells
US8729040B2 (en) 2008-05-29 2014-05-20 The Board Of Trustees Of The Leland Stanford Junior University Cell line, system and method for optical control of secondary messengers
JP5887136B2 (ja) 2008-06-17 2016-03-16 ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー 細胞発達を制御するための装置および方法
US20110097731A1 (en) * 2008-06-25 2011-04-28 Novartis Forschungsstiftung, Zweigniederlassung Friedrich Mischer Institute for Biomedical Researc Novel mitochondrial dye
WO2010006049A1 (fr) 2008-07-08 2010-01-14 The Board Of Trustees Of The Leland Stanford Junior University Matériaux et approches pour stimulation optique du système nerveux périphérique
NZ602416A (en) 2008-11-14 2014-08-29 Univ Leland Stanford Junior Optically-based stimulation of target cells and modifications thereto
WO2010111208A1 (fr) * 2009-03-23 2010-09-30 University Of Miami Inhibiteurs mitochondriaux et utilisations correspondantes
ES2676274T3 (es) 2010-03-17 2018-07-18 The Board Of Trustees Of The Leland Stanford Junior University Moléculas sensibles a la luz que permiten el paso de iones
EP2635346B1 (fr) 2010-11-05 2017-03-29 The Board of Trustees of the Leland Stanford Junior University Régulation optogénétique de comportements associés au système de récompense
EP2635109A4 (fr) 2010-11-05 2014-03-19 Univ Leland Stanford Junior Dysfonctionnement du snc contrôlé optiquement
WO2012061679A2 (fr) 2010-11-05 2012-05-10 The Board Of Trustees Of The Leland Stanford Junior University Opsines chimériques activées par la lumière et leurs procédés d'utilisation
EP2635111B1 (fr) 2010-11-05 2018-05-23 The Board of Trustees of the Leland Stanford Junior University Protéines stabilisées de type opsine a fonction discontinue (ssfo) et leurs procédés d'utilisation
US9522288B2 (en) 2010-11-05 2016-12-20 The Board Of Trustees Of The Leland Stanford Junior University Upconversion of light for use in optogenetic methods
CA2816972C (fr) 2010-11-05 2019-12-03 The Board Of Trustees Of The Leland Stanford Junior University Controle et caracterisation de la fonction memoire
US8696722B2 (en) 2010-11-22 2014-04-15 The Board Of Trustees Of The Leland Stanford Junior University Optogenetic magnetic resonance imaging
EP2694667B1 (fr) * 2011-04-08 2016-12-07 Baystate Medical Center, Inc. Procédés, compositions et nécessaires permettant d'analyser la fonction mitochondriale
CN104093833B (zh) 2011-12-16 2017-11-07 斯坦福大学托管董事会 视蛋白多肽及其使用方法
ES2628006T3 (es) 2012-02-21 2017-08-01 Circuit Therapeutics, Inc. Composiciones para el tratamiento de trastornos neurogénicos del suelo pélvico
WO2014144409A1 (fr) 2013-03-15 2014-09-18 The Board Of Trustees Of The Leland Stanford Junior University Contrôle optogénétique de l'état comportemental
US9636380B2 (en) 2013-03-15 2017-05-02 The Board Of Trustees Of The Leland Stanford Junior University Optogenetic control of inputs to the ventral tegmental area
JP6549559B2 (ja) 2013-04-29 2019-07-24 ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー 標的細胞における活動電位の光遺伝学的調節のための装置、システム及び方法
EP3033427A4 (fr) 2013-08-14 2017-05-31 The Board Of Trustees Of The University Of the Leland Stanford Junior University Compositions et procédés pour réguler une douleur
US10568516B2 (en) 2015-06-22 2020-02-25 The Board Of Trustees Of The Leland Stanford Junior University Methods and devices for imaging and/or optogenetic control of light-responsive neurons
US11294165B2 (en) 2017-03-30 2022-04-05 The Board Of Trustees Of The Leland Stanford Junior University Modular, electro-optical device for increasing the imaging field of view using time-sequential capture
US12006553B2 (en) 2017-05-19 2024-06-11 Lunella Biotech, Inc. Companion diagnostics for mitochondrial inhibitors
CA3148248A1 (fr) * 2019-07-24 2021-01-28 Luca Science Inc. Procede d'obtention de mitochondries a partir de cellules et mitochondries ainsi obtenues
CN113069530B (zh) * 2021-03-31 2022-01-25 河南大学 萘酰亚胺-多胺衍生物联合环孢素a在制备抗肿瘤药物中的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5015568A (en) 1986-07-09 1991-05-14 The Wistar Institute Diagnostic methods for detecting lymphomas in humans
US5049673A (en) 1987-10-30 1991-09-17 The Regents Of The University Of California Fluorescent indicator dyes for calcium working at long wavelengths
US5501980A (en) 1994-05-20 1996-03-26 Molecular Probes, Inc. Benzazolylcoumarin-based ion indicators
US5888498A (en) 1995-03-03 1999-03-30 Mitokor Cellular and animal models for diseases associated with mitochondrial defects
US6183948B1 (en) * 1998-04-15 2001-02-06 Johns Hopkins University Methods to identify compounds affecting mitochondria

Also Published As

Publication number Publication date
WO2001051923A3 (fr) 2002-05-02
US6808873B2 (en) 2004-10-26
WO2001051923A2 (fr) 2001-07-19
US20050170329A1 (en) 2005-08-04
EP1247093B1 (fr) 2005-03-23
DE60109571D1 (de) 2005-04-28
US20010046664A1 (en) 2001-11-29
EP1247093A2 (fr) 2002-10-09
ATE291737T1 (de) 2005-04-15

Similar Documents

Publication Publication Date Title
AU2001241420A1 (en) Screening assays using intramitochondrial calcium
CY1108725T1 (el) Συνδυασμος ανταγωνιστου-nmda και αναστολεων ακετυλοχολινεστερασης δια την θεραπειαν της νοσου alzheimer
BR0211274A (pt) Combinação de um antagonista de receptor de aldosterona e um inibidor de hmg co-a redutase
WO2000055609A3 (fr) Systeme et methode d'authentification
FI974368A (fi) Kasvuhormonin vapautumista edistäviä dipeptidejä
DK1296671T3 (da) Gabapentinanaloger til sövnforstyrrelser
DK0705100T3 (da) Terapeutiske substituerede guanidiner
WO2005016455A3 (fr) Anticorps variables
BRPI0110506B8 (pt) uso de inibidores de il-18 para o tratamento e/ou prevenção da aterosclerose
ES2216630T3 (es) Metodos de tratar la hipertension dependiente de la sal.
GB0102879D0 (en) Triboluminescent devices
BR0307048A (pt) Composição farmacêutica orodispersìvel de perindoprila
EP0858262A4 (fr) Inhibiteurs de thrombine
IL106237A0 (en) Piperidyl amides,sulfonamides and sulfoxamides as inhibitors of cholesterol biosynthesis
IL161116A (en) Use of irbesartan for the preparation of medicinal products that are useful for preventing or treating pulmonary arterial hypertension
MX9603045A (es) Antagonistas de los receptores endoteliales.
WO2001051922A3 (fr) Procedes pour identifier les agents liant le recepteur de benzodiazepine peripherique
CY1105504T1 (el) Νεες συνθετες κρυσταλλικες δομες που περιεχουν φυτοστερολες και φυτοστανολες ή παραγωγα αυτων
MXPA03001331A (es) Metodos y moleculas utiles para identificar moleculas que se enlazan alfa-1 y para determinar la ocupacion del receptor.
ATE289513T1 (de) Verwendung eines phosphatadsorbers gegen gefässerkrankungen
DE50309337D1 (de) Calcium enthaltende süssigkeit
AU1506692A (en) Pharmaceutical compositions
GB2389814B (en) Improvements in paper
AU2000277598A1 (en) Lrp-mediated modulation of neuronal calcium influx via nmda receptors, and uses thereof
AU2001256406A1 (en) Use of anethole-dithiolethione for preventing and treating drug-induced tendon toxicity